ArticleJournal of ophthalmology2026
Evaluation of Macular Thickness, Choroidal Thickness, and Choroidal Vascularity Index in Women With Polycystic Ovary Syndrome: A Cross-Sectional Study.
Article in Journal of ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Evaluation of Macular Thickness, Choroidal Thickness, and Choroidal Vascularity Index in Women With Polycystic Ovary Syndrome: A Cross-Sectional Study.Journal of ophthalmology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To evaluate macular thickness, choroidal thickness, and choroidal vascularity index (CVI) in women with polycystic ovary syndrome (PCOS), and to assess the possible relationship between these parameters and sex hormone levels. Methods: This cross-sectional study included 41 women with PCOS and 46 age-matched healthy controls. All participants underwent a comprehensive ophthalmologic examination and spectral-domain optical coherence tomography (SD-OCT) with enhanced depth imaging (EDI) mode. The right eye of each participant was included in the analysis. Choroidal thickness was measured at five predefined locations. CVI and CVI1500 were calculated from binarized EDI-OCT images using ImageJ software. Hormonal, metabolic, and lipid parameters were recorded. Statistical analyses included independent samples Results: Subfoveal and 1000 µm nasal choroidal thicknesses were significantly greater in the PCOS group ( Conclusions: PCOS is associated with increased choroidal vascularity and selected choroidal thickness parameters. CVI may represent a potential imaging marker of subclinical choroidal vascular alterations in PCOS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.